Currently, out of the existing stock ratings of Raghuram Selvaraju - 355 which are a Buy (98.07%), 7 which are a Hold (1.93%)

Raghuram Selvaraju

Work Performance Price Targets & Ratings Chart

Analyst Raghuram Selvaraju works at HC WAINWRIGHT and is covering Healthcare, Basic Materials sectors with 731 price targets and ratings displayed on 63 stocks. Previously, Raghuram Selvaraju worked at AEGIS.

Raghuram Selvaraju's average stock forecast success ratio is 16.73% with an average time for price targets to be met of 104.58 days.

Most recent stock forecast was given on INDP, at 20-Sep-2023.

Wall Street Analyst Raghuram Selvaraju

Analyst best performing recommendations are on AEZS (AETERNA ZENTARIS).
The best stock recommendation documented was for AEZS (AETERNA ZENTARIS) at 11/24/2015. The price target of $275 was fulfilled within 1 day with a profit of $83 (43.23%) receiving and performance score of 432.29.

Average potential price target upside

AMRN Amarinplc BCPC Balchem CHEK CheckCap Ltd CODX CoDiagnostics CPRX Catalyst Pharmaceuticals ETON Eton Pharmaceuticals EVOK Evoke Pharma INO Inovio Pharmaceuticals RKDA Arcadia Biosciences SRNE Sorrento Therapeutics ABEO Abeona Therapeutics ADMS Adamas Pharmaceuticals AEZS Aeterna Zentaris ANGN AQST Aquestive Therapeutics AYLA Ayala Pharmaceuticals BBI BBIO BridgeBio Pharma BTAI BioXcel Therapeutics BWAY Brainsway Ltd CDXC ChromaDex CRDF EQ Equillium EVFM Evofem Biosciences GMAB Genmab A/S GRTX Galera Therapeutics ITMR Itamar Medical Ltd KZR OBSV ObsEva SA OMER Omeros ORMP Oramed Pharmaceuticals RDHL RedHill Biopharma Ltd ADXN TMBR URGN UroGen Pharma Ltd APTX Aptinyx RAPT RAPT Therapeutics SLGL SolGel Technologies Ltd SPRO TALS GANX VRNA Verona Pharma plc ADMA ADMA Biologics AVXL Anavex Life Sciences RMTI Rockwell Medical SELB Selecta Biosciences RVPH KRTX Karuna Therapeutics ENTX ACRS Aclaris Therapeutics ANVS AXSM Axsome Therapeutics COCP ENLV FENC INDP INM MLTX ONCT PRVB Provention Bio SPRB Spruce Biosciences STML TARO

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$0.05 (5.26%)


2 months 1 days ago

8/9 (88.89%)

$0.6 (18.39%)




$2.05 (215.79%)


8 months 15 days ago

4/16 (25%)

$8.22 (56.00%)



1 years 3 months 15 days ago

2/4 (50%)

$4.78 (37.42%)




$18.05 (1900.00%)


1 years 10 months 18 days ago

0/23 (0%)

$14.53 (233.04%)



$15.05 (1584.21%)


2 years 7 months 20 days ago

0/6 (0%)

$6.74 (91.65%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Raghuram Selvaraju is most bullish on?

Potential upside of $126.3 has been obtained for KRTX (KARUNA THERAPEUTICS)

Which stock is Raghuram Selvaraju is most reserved on?

Potential downside of -$0 has been obtained for TALS

What Year was the first public recommendation made by Raghuram Selvaraju?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart